Latest News

For the eighth consecutive year, the Department of Emergency Medicine at Yale School of Medicine was recognized among the nation’s leaders in National Institutes of Health (NIH) research funding, ranking #2 in the U.S. according to the Blue Ridge Institute for Medical Research. This year’s achievement is marked by an extraordinary expansion in faculty success, with 14 faculty members receiving NIH funding and 9 among the top 100 NIH-funded emergency medicine investigators nationwide.

A new study published in JAMA Network Open reveals that participation in emergency department-based clinical trials delivers substantial benefits that extend far beyond improved patient outcomes.

In a Yale study, researchers found that seven-day injectable buprenorphine and daily tablet buprenorphine are equally safe and effective in engaging patients with opioid use disorder in treatment after an emergency department visit.

In a new study published in JAMA Network Open, Yale researchers examined the burdens for people who use public transit to access methadone treatment for opioid use disorder (OUD) at Opioid Treatment Programs (OTPs) in Connecticut.

FORE has awarded a grant of $917,027 to Yale University to establish the National Methadone Access and Quality Commission (NMAQC), a new national initiative focused on improving access to methadone, an evidence-based treatment for people with opioid use disorder (OUD).

A new Yale study examines whether survival differences by race and ethnicity persist among patients with do-not-attempt-resuscitation orders placed early after cardiac arrest.

Yale School of Public Health researchers say that a dramatic increase in the use of opioid disorder medications in residential treatment facilities over the past decade was driven by a new Medicaid reimbursement plan and new treatment facilities entering the market. The insight may prove helpful for policymakers seeking to improve the quality of care.

Fuad Abujarad, PhD, associate professor of emergency medicine, has been named the 2025 Outstanding Partner by the Area Agency on Aging of South Central Connecticut (AOASCC). This award honors Abujarad’s groundbreaking work harnessing digital health tools to empower older adults and strengthen community-based aging support.

Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress.